Jennifer Liscouski

Jennifer Liscouski has extensive experience in the field of regulatory affairs. Jennifer currently holds the position of Vice President and Head of Regulatory Affairs at Spero Therapeutics, a role they have held since June 2021. Prior to this, they served as the Senior Director and Head of Regulatory Affairs at Spero Therapeutics from January 2019 to June 2021.

Before joining Spero Therapeutics, Jennifer worked at Arsanis as the Senior Director of Regulatory Affairs and Quality from January 2018 to January 2019. Jennifer also has experience as an Independent Consultant, providing regulatory affairs expertise, from February 2016 to December 2017.

Jennifer's earlier work experience includes a long tenure at Cubist Pharmaceuticals, where they held the position of Director of Regulatory Affairs from April 2005 to October 2015. Jennifer began their career in regulatory affairs at Sention as a Senior Associate, a position they held from an unspecified time in 2001 to 2005.

Jennifer Liscouski attended the University of Rhode Island from 1997 to 2001. However, no specific information was provided regarding the degree or field of study pursued during this time.